Novo Nordisk Enters Collaboration with University of Oxford on Type 2 Diabetes and Invests £115m in New Research Centre
The University of Oxford and Novo Nordisk have just announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and The University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the collaboration, Novo Nordisk is also investing in a new research centre on the premises of the University of Oxford.

The Novo Nordisk Research Centre Oxford will employ up to 100 Novo Nordisk researchers, based in an Oxford University research centre. The total investment from Novo Nordisk is expected to be around 1 billion Danish kroner (115 million British pounds) over a period of 10 years. The centre will focus on innovation within early stage research that has potential to substantially impact future treatment of type 2 diabetes and its complications. More
OBN Members Get 25% Off 'Knowledge for Growth' Registrations
Knowledge for Growth is Belgium's leading life sciences conference, taking place on May 18th, 2017 in Ghent, Belgium. This high-level networking event attracts decision makers from biotech, pharma and medtech as well as investors, universities, top notch research institutes, policymakers and competence providers.

The conference features an exciting programme providing vital insight into the global life sciences' landscape, B2B Partnering powered by EBD Group's partneringLITE, a trade fair with 100 exhibitors and a scientific poster area. Click here for more information.
University of Oxford to Host Two AIMDays on Ageing and Microscopy
The AIMday concept has been successfully pioneered by the University of Uppsala, Sweden and used in a wide variety of contexts. The University of Oxford will be hosting two AIMdays, the first on 03 July will focus on Ageing, the second on 17 July will look at Microscopy. It is a no-cost opportunity for companies and organisations to exchange knowledge and ideas with Oxford University academics and clinical researchers.

AIMdays provide a platform for external organisations to make connections with academia that they may have, in the past, struggled to achieve. In particular, this event will provide an opportunity to access the wide range of excellent research being conducted at the University of Oxford with the aim of bridging the knowledge gap between research and industry.

Companies and organisations interested in attending must submit at least one question. This is done using the AIMdays event portal before 31st March 2017. More information on posing questions and example questions can be found together with information on the Ageing AIMday here and the Microscopy AIMday information is here.
Last Few Places Available at North West Training Event
OBN's ever popular half day training course 'How the drug discovery industry works' comes to Alderley Park Conference Centre this week.
Most suitable for those who are new to the drug discovery industry, in non-scientific roles or beginning careers as a scientist, to help gain or develop in depth knowledge of the sector. There are a few places left, click here to find out more.
Forthcoming OBN Events
Future events from OBN. Click the links below for more information and  to  register.

Other Forthcoming Events
Future events from OBN Members and other organisations. Click the links below for more information and  to  register.

OBN Purchasing Consortium - Are You Considering Outsourcing Your R&D?
If you are considering outsourcing some or all then take a look at two of the suppliers to the OBN Purchasing Consortium.  They both offer special pricing to Consortium Members.

Sygnature Discovery is the UK's largest independent provider of premium integrated drug discovery resource, delivering advanced scientific expertise into drug discovery programs for pharmaceutical and biotechnology companies worldwide. Their capabilities include medicinal chemistry, bioscience, DMPK, computational chemistry, project management and informatics.

CEM Analytical Services "CEMAS" is a leading GXP analytical chemistry laboratory, specialising in mass spectrometry (gas, liquid, ICP), and providing full analytical method development, validation and transfer.  Pharmaceuticals testing undertaken includes GCP bioanalysis, GMP stability testing and GMP quality control testing.

For more information about the OBN Purchasing Consortium click here or email Lee Pratley.
31 January 2017
OBN Website
Latest Jobs
This is just a selection of the latest national and international jobs. Click the links for more information and to apply.


Latest News
The latest news from OBN Members and the wider life sciences industry. Click the links for more information.

New OBN Members
A warm welcome to the latest company joining OBN's rapidly expanding Membership. Click the logo to see their website:

Tell Us
If you have any News, Jobs or Events you would like to share with OBN Members and Contacts email Stephen Barton with the details
 BioTrinity 2017 Will Be Our Biggest Yet: Click the Banner to Register
OBN is sponsored by: